The level of cotinine - Marker of tobacco smoking, in patients with hyperthyroidism;Stȩżenie kotyniny - markera nikotynizmu - u pacjentów z nadczynnościa̧ tarczycy

Endokrynologia Polska

Volumn 57, Issue 6, 2006, Pages 612-618

  Czarnywojtek, Agata ^a   Zgorzalewicz Stachowiak, Małgorzata ^a   Florek, Ewa ^a   Piekoszewski, Wojciech ^b   Warmuz Stangierska, Izabela ^a   Kulińska Niedziela, Izabela ^a   Komar Rychlicka, Krzesisława ^a   Sowiński, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

Cotinine; Graves' disease; Hyperthyroidism; Tobacco smoking

Indexed keywords

BIOLOGICAL MARKER; COTININE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; MIDDLE AGED; SMOKING; URINE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COTININE; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MIDDLE AGED; SMOKING;

EID: 34250667639     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bednarczuk T, Hiromatsu Y, Seki N i wsp. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum Immunol 2004; 65 (6): 632-639.
2. Kula D, Bednarczuk T, Jurecka-Lubieniecka B i wsp. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1&z.ast;07. Thyroid 2006; 16 (5): 447-453.
3. Wiersinga WM. The philosophy of Graves' ophthalmopathy. Orbit 2005; 24 (3): 165-171.
4. Tellez M, Cooper J, Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol (Oxf) 1992; 36: 291-294.
5. Wakelkamp IM, Gerding MN, van der Meer JW i wsp. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy. Clin Exp Immunol 2002; 127 (2): 316-320.
6. Fagerström KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 1989; 12: 159-182.
7. Tricker AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2003; 183 (1-3): 151-173.
8. Bramer SL, Kaiiungal BA. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 2003; 8 (3-4): 187-203.
9. Seccareccia F, Zuccaro P, Pacifici R i wsp. Research Group of the MATISS Project. Serum cotinine as a marker of environmental tobacco smoke exposure in epidemiological studies: the experience of the MATISS project. Eur J Epidemiol 2003; 18 (6): 487-492.
10. Mourits MP, Koornneef L, Wiersunga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assesment of disease activity in Graves' ophthalmopathy. Endocrine Rev 2000; 21: 168-199.
11. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Commitee of the American Thyroid Association (letter). JCEM 1977; 44: 203-204.
12. Bartalena L, Pinchera A, Marcocci C. Management of Graves' opthalmopathy: reality and perspectives. Endocrine Rev 2000; 21: 168-199.
13. Ruchała M. Wpływ palenia papierosów na funkcje gruczołów wydzielania wewnȩtrznego. Tytoń albo zdrowie - fakty medyczne. Materiały pokonferencyjne pod redakcja̧ Szczepana Cofty, Poznań. Wydawnictwo Miejskie 2004; 35-37.
14. Myśliwiec J, Kinalska I. Cigarette smoking-the defined risk factor of ophthalmopathy in Grave's disease. Pol Arch Med Wewn 2001; 106 (4): 967-971.
15. Bednarek J, Wysocki H, Sowiński J. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clin Biochem 2005; 38 (1): 13-18.
16. Salvi M, Pedrazzoni M, Girasole G i wsp. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000; 143: 197-201.
17. Wakelkamp IM, Gerding MN, van der Meer JW i wsp. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol 2000; 121 (3): 453-437.
18. Florek E, Marszałek A. An experimental study of the influence of tobacco smoke on fertility and reproduction. Hum Exp Toxicol 1999; 18: 272-278.
19. Weetman AP, Zhang L, Webb S i wsp. Analysis of HLA-DQB and HLA DPB alleles in Graves' disease by oligonucleotide probing of enzymatically amplified DNA. Clin Endocrinol 1990; 33: 65-71.
20. Perros P, Kendall-Taylor P. Pathogenetic mechanisms in thyroid-associated ophthalmopathy. J Intern Med 1995; 231: 205-211.
21. Vestergaad P. Smoking and thyroid disorders - a meta-analysis. Eur J Endocrinol 2002; 146: 153-161.
22. Metcalfe RA, Weetman AP. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) 1994; 40: 67-72.